Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy - Wikidata - awgldk - TriplyDB

Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy

Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy

http://www.wikidata.org/entity/Q33784635

about

Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632 Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.Zidovudine and Lamivudine for HIV Infection.Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Genetic drift and within-host metapopulation dynamics of HIV-1 infection Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitors Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection.Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.Procedures for reliable estimation of viral fitness from time-series data.

P2860

Q24554340-9BFE3B98-3C6C-4206-B8A7-0B1417F2159E Q27640250-16051461-56F6-4631-8C9C-FC38C80725D7 Q28344594-241B8833-4A0E-448F-B722-A8163FA2C36E Q33846032-7DAB1600-18E9-4C85-AA8A-5C3881196348 Q33912028-C393AECE-1FFE-4B5A-B537-8C8542AD670A Q34194561-42161438-6BAD-4C72-A295-A8C26D2E4705 Q34454630-B5D09384-0884-43E6-B900-7DD882FB65D7 Q34545639-9991F321-9A6D-4378-9993-E68E7F992DAA Q35179391-EB3A8902-BF44-43EC-8BF8-BB510189BBB3 Q35647691-0EC8FD97-64D8-4F96-9E3D-6C3B7AED43F6 Q35742512-EC2AE907-C233-4642-BC05-4302F14D9E41 Q36259922-7C81D2A9-4A36-47B8-8864-A24BD039F931 Q36954674-32DFEC40-2A8E-4166-B434-EDB9EC106453 Q37093847-1A919700-E604-46B3-9D40-82E017DC64CD Q37596952-6EBFCC1D-0502-4D5C-B4E5-A87A4BEF328D Q39549108-DE893763-6BDA-4D58-84EA-3B8F01D37C33 Q39550343-55B4BB2D-E1F1-4190-8D1F-75DFA633CEB4 Q39591902-07FD117A-6016-4AAC-BE58-9100E1E2ED5E Q39685276-17F849A4-B76D-4D41-A576-276058D020DD Q42931192-E134CDB3-73A1-47BF-B70B-C38891E8909D Q53957669-5C05EEE4-7CC1-4B54-8589-CFFFC35ACBCE

P2860

Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy

http://www.wikidata.org/entity/Q33784635

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@ast

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@en

type

label

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@ast

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@en

prefLabel

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@ast

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@en

P1433

Q33784635-889B3375-26D4-4E13-80AE-AE8E7AD444A5

P1476

Q33784635-3F4F8B7E-E6FC-43A2-B894-DB497529111B

P2093

Q33784635-10730511-DA2D-451B-B4BC-19B4047AB01B

Q33784635-202141CA-D5BC-4794-AAB2-469B232F022E

Q33784635-34C1D717-A45D-45F4-A699-A744396FEA71

Q33784635-558ECB53-8BCE-4CE6-8C89-9D191267D887

Q33784635-58D183AD-449E-4C97-80C4-8F1E000E258E

Q33784635-7C275AD1-6211-45EF-9A9C-01BC5B41F918

Q33784635-99B4384C-54EA-4A41-8165-1185510DE2F2

Q33784635-A8AB5B12-1BDD-4542-8555-E950C1E3595E

Q33784635-C69BAEC4-3DD1-4FBF-A149-32F40CF22E6B

Q33784635-F058AAC2-F338-4FA1-86D0-499716488A51

P2860

Q33784635-0A31B99D-A19B-4C04-BEC1-9C57F503182E

Q33784635-0BF0CC23-E400-4EC1-A7E1-4D3D6C60004F

Q33784635-0CFCFBF8-426C-46EC-91C0-27B25608CA2D

Q33784635-1819FDE4-BB5E-4933-B1BA-60DE3A262BCD

Q33784635-1BAA32B2-2640-4802-8A22-7D90F543A530

Q33784635-2D25E767-2E5D-4485-AD9D-FEF25D43E2AB

Q33784635-2E02C23A-28F6-46A9-AAB3-6D331FEF1553

Q33784635-2EB1DB7C-F06D-4EBD-8D35-654E1D07DFEC

Q33784635-329159DC-CA86-4168-96A1-D042CEE7600F

Q33784635-39081D73-AFEB-4172-A4E1-BADF879C4FF4

P304

Q33784635-3B150DE2-917E-42D6-AF34-F71C2050C7BF

P31

Q33784635-688E99C2-5A2E-4410-9B95-FE2D0708B13E

P433

Q33784635-2CF42237-9202-414B-95C5-D5B75FB831EC

P478

Q33784635-9E03750B-5473-444F-9095-7713B01CF3AE

P577

Q33784635-C19FC312-2443-4AB2-97DF-B45097B4B2B8

P698

Q33784635-83821F27-FE5A-4F8F-9B08-5E4E002261B5

P932

Q33784635-8F4B0128-93EF-445D-9CB0-8130E6D7E0AF

P1433

Journal of Virology

P1476

Genotypic changes in human imm ...... ritonavir (Norvir) monotherapy

@en

P2093

C Gee

http://www.w3.org/2001/XMLSchema#string

D W Norbeck

http://www.w3.org/2001/XMLSchema#string

E Boyer

http://www.w3.org/2001/XMLSchema#string

H Mo

http://www.w3.org/2001/XMLSchema#string

J Kolberg

http://www.w3.org/2001/XMLSchema#string

J M Leonard

http://www.w3.org/2001/XMLSchema#string

J Mittler

http://www.w3.org/2001/XMLSchema#string

M Markowitz

http://www.w3.org/2001/XMLSchema#string

M Urdea

http://www.w3.org/2001/XMLSchema#string

P S Eastman

http://www.w3.org/2001/XMLSchema#string

P2860

Active human immunodeficiency virus protease is required for viral infectivity

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

P304

5154-5164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9573287

http://www.w3.org/2001/XMLSchema#string

P932

110088

http://www.w3.org/2001/XMLSchema#string